You need to enable JavaScript to run this app.
Regulatory Recon: Gates Makes $100M Investment in Alzheimer's R&D J&J, Zymeworks Enter Potential $1B Discovery Pact (13 November 2017)
Recon
Regulatory News
Michael Mezher